⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Tata Ethical Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Tata MF | HDFC MF |
| Category | Equity - Thematic Fund - Other | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹403.44 (29 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★ | ★★★★★ |
| Benchmark | Nifty500 Shariah - TRI | BSE Health Care - TRI |
| Fund Manager | Abhinav Sharma | Nikhil Mathur |
| Inception | 01 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | -8.88% | 22.64% |
| 3Y | 5.47% | 30.41% |
| 5Y | 6.38% | — |
| Since Inception | 13.10% | 29.15% |
| Risk | ||
| 13.21 | 14.07 | |
| 0.88 | 0.59 | |
| -0.07 | 1.59 | |
| -2.03 | 21.67 | |
| -0.12 | 3.48 | |
| -9.95% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.82% | 1.03% |
| Exit Load | 0.50% on or before 90D, Nil after 90D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Tata MF90%
HDFC MF90%
10.0%Only 10.0% of holdings by weight are common between Tata MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingTata MFHDFC MF
Dr. Reddy's Laboratories Ltd.3.37%3.19%
Cipla Ltd.2.36%4.15%
Sun Pharmaceutical Industries Ltd.2.34%8.28%
Alkem Laboratories Ltd.2.14%4.64%
Category context: Equity vs Equity. Open the full Screener →